betamethasone-17,21-dipropionate has been researched along with methylprednisolone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| David, M; Hodak, E; Neeman, A; Sandbank, M; Trattner, A | 1 |
| Eubanks, LE; Galen, W; McBurney, EI; Reed, R | 1 |
| Cordoba-Guijarro, S; Fernández-Redondo, V; García-Doval, I; Gatica-Ortega, ME; Giménez-Arnau, A; González-Pérez, R; Mercader-García, P; Pastor-Nieto, MA; Serra-Baldrich, E; Silvestre-Salvador, JF | 1 |
| Nixon, R; Shen, S; Wong, GN | 1 |
| Bradford, J; Chin, S; Fischer, G; Lee, G; Scurry, J | 1 |
| Brown, H; Jenkins, D; Lamrock, E | 1 |
| Jurs, PC; Stouch, TR | 1 |
| Bodor, N; Harget, AJ; Phillips, EW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
1 review(s) available for betamethasone-17,21-dipropionate and methylprednisolone
| Article | Year |
|---|---|
Linear scleroderma in children.
Topics: Administration, Topical; Adolescent; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Betamethasone; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Penicillins; Phenytoin; Scleroderma, Localized; Ticlopidine; Vitamin E | 1996 |
8 other study(ies) available for betamethasone-17,21-dipropionate and methylprednisolone
| Article | Year |
|---|---|
Kaposi's sarcoma with visceral involvement after intraarticular and epidural injections of corticosteroids.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Humans; Injections, Intra-Articular; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Sarcoma, Kaposi; Ulnar Nerve Compression Syndromes | 1993 |
Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study.
Topics: Administration, Cutaneous; Adult; Betamethasone; Betamethasone Valerate; Clobetasol; Dermatitis, Allergic Contact; Dermatologic Agents; Female; Humans; Hydrocortisone; Male; Methylprednisolone; Mometasone Furoate; Patch Tests; Predictive Value of Tests; Prednisolone; Prevalence; Prospective Studies; Spain | 2018 |
Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Bufexamac; Chemotherapy, Adjuvant; Dermatitis, Allergic Contact; Edema; Erythema; Facial Dermatoses; Histamine Antagonists; Hospitalization; Humans; Methylprednisolone; Ointments | 2019 |
Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Carcinoma in Situ; Carcinoma, Squamous Cell; Clobetasol; Desonide; Female; Humans; Hydrocortisone; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Vulvar Lichen Sclerosus; Vulvar Neoplasms | 2020 |
Bullous pemphigoid in adolescence, a rare demographic.
Topics: Adolescent; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Betamethasone; Female; Glucocorticoids; Humans; Methylprednisolone; Mycophenolic Acid; Pemphigoid, Bullous; Prednisone | 2021 |
Computer-aided studies of the structure-activity relationships between the structure of some steroids and their antiinflammatory activity.
Topics: Anti-Inflammatory Agents; Humans; Numerical Analysis, Computer-Assisted; Steroids; Structure-Activity Relationship; Vasoconstriction | 1986 |
Structure-activity relationships in the antiinflammatory steroids: a pattern-recognition approach.
Topics: Animals; Anti-Inflammatory Agents; Drug Synergism; Granuloma; Humans; Models, Chemical; Rats; Steroids; Structure-Activity Relationship; Vasoconstriction | 1983 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |